Article
Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing.
Molecular diagnosis & therapy - 1 Oct 2018
Goldman Jill S, Van Deerlin Vivianna M
Abstract excerpt
The advent of next-generation sequencing has changed genetic diagnostics, allowing clinicians to test concurrently for phenotypically overlapping conditions such as Alzheimer's disease (AD) and frontotemporal dementia (FTD). However, to interpret genetic results, clinicians require an understanding of the benefits and limitations of different genetic technologies, such as the inability to detect large repeat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
